Literature DB >> 25736702

Preventability of adverse effects of analgesics: analysis of spontaneous reports.

Irina Cazacu1, Ghada Miremont-Salamé, Cristina Mogosan, Annie Fourrier-Réglat, Felicia Loghin, Françoise Haramburu.   

Abstract

OBJECTIVES: The aims of this study were to determine the patterns of analgesic adverse drug reactions (ADRs) and to assess their preventability and contributing factors.
METHODS: This is a retrospective, descriptive study conducted on ADRs of analgesics and other drugs indicated as analgesics, spontaneously reported to the Bordeaux pharmacovigilance center from January 2011 to June 2012.
RESULTS: The 141 cases selected for the analysis included 16 cases of medication errors (11.3%) and 15 addiction cases (10.6%). In total, 214 ADRs were registered, for which 173 analgesic medicines were suspected. The most frequent ADRs reported were nervous system disorders (26.6%), psychiatric disorders (15.0%), and skin and subcutaneous tissue disorders (12.1%). Tramadol alone or in combination (17.3%), followed by morphine (15%), fentanyl (9.8%), and paracetamol (8.7%) were the most frequently involved analgesics. More than half of the cases (54.6%) were serious and led to hospitalization or prolonged hospitalization. Preventability was determined for 134 cases (95%): 51.5% were considered as preventable, 26.1% not preventable, and 22.4% not assessable. The main contributing factors for the preventable cases included negligence of recommendations for analgesic use and failure to consider patients' risk factors when prescribing.
CONCLUSIONS: A significant number of analgesic ADRs could be prevented, and being aware of their contributing factors promotes efficient analgesia with minimum risks to the patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25736702     DOI: 10.1007/s00228-015-1829-8

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database.

Authors:  Guillaume Moulis; Agnès Sommet; Geneviève Durrieu; Haleh Bagheri; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

2.  [Validation of a measurement scale: example of a French Adverse Drug Reactions Preventability Scale].

Authors:  Pascale Olivier; Jacques Caron; Françoise Haramburu; Jean-Louis Imbs; Annie-Pierre Jonville-Béra; Georges Lagier; Catherine Sgro; Thierry Vial; Jean-Louis Montastruc; Maryse Lapeyr-Mestre
Journal:  Therapie       Date:  2005 Jan-Feb       Impact factor: 2.070

Review 3.  Misuse of medicines in the European Union: a systematic review of the literature.

Authors:  Alicia Casati; Roumen Sedefov; Tim Pfeiffer-Gerschel
Journal:  Eur Addict Res       Date:  2012-05-04       Impact factor: 3.015

4.  Evolution of opioids reimbursement since 2004 from the National Database of the General Health Insurance System.

Authors:  Vanessa Pauly; Vincent Pradel; Elisabeth Frauger; Joelle Micallef; Xavier Thirion
Journal:  Therapie       Date:  2011-08-19       Impact factor: 2.070

5.  [Which analgesic after dextropropoxyphene withdrawal? A survey in a sample of general practitioners in southwest of France].

Authors:  Serge Bismuth; Eng Laing Leng; Stéphane Oustric; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal:  Therapie       Date:  2011-04-07       Impact factor: 2.070

6.  Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.

Authors:  Johanna Jyrkkä; Hannes Enlund; Maarit J Korhonen; Raimo Sulkava; Sirpa Hartikainen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

7.  Medication errors with opioids: results from a national reporting system.

Authors:  Sydney Morss Dy; Andrew D Shore; Rodney W Hicks; Laura L Morlock
Journal:  J Opioid Manag       Date:  2007 Jul-Aug

8.  Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.

Authors:  Anne Bénard-Laribière; Ghada Miremont-Salamé; Marie-Christine Pérault-Pochat; Pernelle Noize; Françoise Haramburu
Journal:  Fundam Clin Pharmacol       Date:  2014-09-25       Impact factor: 2.748

9.  Drug prescription in young children: results of a survey in France. Epicrèche Research Group.

Authors:  J P Collet; N Bossard; D Floret; J Gillet; D Honegger; J P Boissel
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

10.  Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.

Authors:  I Lacroix; C Hurault; M F Sarramon; C Guitard; A Berrebi; M Grau; C Albouy-Cossard; R Bourrel; E Elefant; J L Montastruc; C Damase-Michel
Journal:  Eur J Clin Pharmacol       Date:  2009-04-14       Impact factor: 2.953

View more
  1 in total

1.  Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database.

Authors:  Hyeong-Geun Jo; Kyeoul Jeong; Ji-Young Ryu; Soyun Park; Yun-Seok Choi; Won-Gun Kwack; Yeo-Jin Choi; Eun-Kyoung Chung
Journal:  J Pers Med       Date:  2021-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.